# MICU/CCU Drips

Patrick Barney

---

Most have order sets in Epic. Typically choose “Titration Allowed” in
ICU

<table>
<colgroup>
<col style="width: 21%" />
<col style="width: 17%" />
<col style="width: 16%" />
<col style="width: 23%" />
<col style="width: 20%" />
</colgroup>
<thead>
<tr class="header">
<th colspan="5">Vasopressors:</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Drug</td>
<td>Dose</td>
<td>Receptors</td>
<td>Indications</td>
<td>Considerations</td>
</tr>
<tr class="even">
<td><strong>Norepinephrine (Levophed)</strong></td>
<td>1 – 100 mcg/min</td>
<td>αα1 &gt; β1</td>
<td>1st line septic shock</td>
<td>Peripheral ischemia, skin necrosis</td>
</tr>
<tr class="odd">
<td><strong>Phenylephrine (Neosynephrine)</strong></td>
<td><p>Bolus: 0.05 – 0.5 mg q 10-15 min</p>
<p>Infusion: 40-360 mcg/min</p></td>
<td>αα1</td>
<td>Periprocedural hypotension (Neostick), pts w/ tachyarrhythmias,
Critical AS or HOCM with severe LVOT obstruction and shock</td>
<td>Reflex bradycardia, Peripheral ischemia, skin necrosis</td>
</tr>
<tr class="even">
<td><strong>Epinephrine</strong></td>
<td>1 – 40 mcg/min</td>
<td>αα1=β1=β2</td>
<td>Post PEA arrest, Anaphylaxis, Septic shock (severe), Cardiogenic
shock</td>
<td>Tachy-arrhythmias, Peripheral ischemia, skin necrosis</td>
</tr>
<tr class="odd">
<td><strong>Vasopressin</strong></td>
<td>0.04 U/min (no titration)</td>
<td>V1, V2, V3</td>
<td>2nd line septic shock, Right heart failure</td>
<td>Hyponatremia, Bradycardia</td>
</tr>
<tr class="even">
<td><p><strong>ANG II</strong></p>
<p><strong>needs approval from MICU leadership</strong></p></td>
<td>20 – 40 ng/kg/min</td>
<td>ANG II</td>
<td>Refractory vasodilatory shock</td>
<td>Thrombosis pt MUST have chemical DVT ppx. Contraindicated in heart
failure</td>
</tr>
<tr class="odd">
<td><strong>Dopamine</strong></td>
<td>2 – 20 mcg/kg/min</td>
<td>Dopamine (1-5 mcg) &gt; β1 (5-10 mcg) &gt;α1 (&gt;10mcg)</td>
<td>Hypotension, Cardiogenic shock</td>
<td>Tachy-arrhythmias, peripheral ischemia, skin necrosis</td>
</tr>
<tr class="even">
<td><strong>Dobutamine</strong></td>
<td>2.5 – 20 mcg/kg/min</td>
<td>β1 &gt;&gt;&gt; β2</td>
<td>Cardiogenic shock</td>
<td>Vasodilation Hypotension, Tachycardia, Tachyphylaxis</td>
</tr>
<tr class="odd">
<td><strong>Milrinone</strong></td>
<td>0.375 – 0.75 mcg/kg/min</td>
<td>PDE-3</td>
<td>Cardiogenic shock</td>
<td>Hypotension, renally cleared</td>
</tr>
</tbody>
</table>

<table>
<colgroup>
<col style="width: 22%" />
<col style="width: 10%" />
<col style="width: 10%" />
<col style="width: 11%" />
<col style="width: 9%" />
<col style="width: 12%" />
<col style="width: 11%" />
<col style="width: 11%" />
</colgroup>
<thead>
<tr class="header">
<th colspan="8">Sedatives/Anxiolytics:</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Drug</td>
<td colspan="2">Dose</td>
<td colspan="2">Class</td>
<td colspan="3">Side effects</td>
</tr>
<tr class="even">
<td><strong>Propofol</strong></td>
<td colspan="2">Infusion: 5 – 150 mcg/kg/min</td>
<td colspan="2">General anesthetic (GABA R agonist)</td>
<td colspan="3"><p>Severe hypotension, bradycardia,
hypertriglyceridemia, propofol infusion syndrome (rare)</p>
<p>Monitor for toxicity with q4 day TGs and CK</p></td>
</tr>
<tr class="odd">
<td><strong>Dexmedetomidine (Precedex)</strong></td>
<td colspan="2">Infusion: 0.1 – 1.5 mcg/kg/h</td>
<td colspan="2">Central αα2 agonist</td>
<td colspan="3">Hypotension, bradycardia</td>
</tr>
<tr class="even">
<td><strong>Midazolam (Versed)</strong></td>
<td colspan="2"><p>Push: 0.5 – 5 mg</p>
<p>Infusion: 0.25 – 5 mg/h (no max dose)</p></td>
<td colspan="2">Benzodiazepine</td>
<td colspan="3">Hypotension, risk of BNZ withdrawal if used for long
periods with sudden discontinuation</td>
</tr>
<tr class="odd">
<td><strong>Lorazepam (Ativan)</strong></td>
<td colspan="2"><p>Push: 0.5 – 10 mg</p>
<p>Infusion: 0.5 – 5 mg/h (no max dose)</p></td>
<td colspan="2">Benzodiazepine</td>
<td colspan="3">Hypotension, propylene glycol carrier - AGMA</td>
</tr>
<tr class="even">
<td><strong>Ketamine</strong></td>
<td colspan="2"><p>Push: 1-2mg/kg</p>
<p>Infusion: 0.2mg/kg/hr, titrate by 0.1 q15min</p></td>
<td colspan="2">NDMA antagonist</td>
<td colspan="3"><p>Delirium/hallucination – use caution in patients with
psychiatric hx, hypertension, tachycardia</p>
<p>Pretreat with 0.4mg IV glycopyrrolate to avoid
hyper-salivation</p></td>
</tr>
<tr class="odd">
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
</tbody>
</table>

<table>
<colgroup>
<col style="width: 21%" />
<col style="width: 29%" />
<col style="width: 48%" />
</colgroup>
<thead>
<tr class="header">
<th colspan="3">Analgesic:</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Drug</td>
<td>Dose</td>
<td>Side effects</td>
</tr>
<tr class="even">
<td><strong>Fentanyl</strong></td>
<td><p>Push: 25 – 100 mcg</p>
<p>Infusion: 25 – 400 mcg/h</p></td>
<td>Hypotension, Serotonin syndrome, chest wall rigidity at high
doses</td>
</tr>
<tr class="odd">
<td><strong>Morphine</strong></td>
<td><p>Push: 1 – 5 mg q1-2h prn</p>
<p>Infusion: 1 – 5 mg/h</p></td>
<td>Hypotension (profound), itching, constipation, HA; avoid in renal
failure</td>
</tr>
<tr class="even">
<td><strong>Hydromorphone (Dilaudid)</strong></td>
<td><p>Push: 0.25 – 1 q1-2h prn</p>
<p>Infusion: 0.5 – 3 mg/h</p></td>
<td>Hypotension, respiratory depression, itching</td>
</tr>
</tbody>
</table>

<table style="width:100%;">
<colgroup>
<col style="width: 16%" />
<col style="width: 15%" />
<col style="width: 19%" />
<col style="width: 13%" />
<col style="width: 16%" />
<col style="width: 18%" />
</colgroup>
<thead>
<tr class="header">
<th colspan="6">Anti-hypertensives</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Drug</td>
<td>Class/MOA</td>
<td>Dose</td>
<td>Indications</td>
<td>Side effects</td>
<td>Comments</td>
</tr>
<tr class="even">
<td><strong>Esmolol</strong></td>
<td>Beta blocker</td>
<td><p>Bolus: 1mg/kg over 30s</p>
<p>Infusion: 50-300mcg/kg/min (max 300)</p></td>
<td>Aortic dissection, HTN emergency</td>
<td>Bradycardia, hypotension</td>
<td>Titrate to desired BP or HR. Caution in HFrEF</td>
</tr>
<tr class="odd">
<td><strong>Nicardipine</strong></td>
<td>CCB</td>
<td>Infusion: 5-15mg/hr (max 15)</td>
<td>HTN emergency</td>
<td>Bradycardia, hypotension</td>
<td>Titrate to desired BP, avoid in HFrEF</td>
</tr>
<tr class="even">
<td><strong>Nitroprusside</strong></td>
<td>Metabolized to NO vasodilatory effect (arterial roughly =
venous)</td>
<td>Infusion: 0.3mcg/kg/min; titrate q2min to max 10mcg/kg/min</td>
<td>HTN E, flash pulmonary edema, HFrEF for afterload reduction</td>
<td>Hypotension, cyanide toxicity</td>
<td>Contraindicated in hepatic and renal failure</td>
</tr>
<tr class="odd">
<td><strong>Nitroglycerin</strong></td>
<td>NO mediated venous &gt; arterial vasodilation</td>
<td>Infusion: start 0.25mcg/kg/min, titrate by 1mcg/kg/min q15min (max
10mcg/kg/min)</td>
<td>Refractory angina, flash pulmonary edema, HTN emergency</td>
<td>Hypotension, headache, palpitations</td>
<td>Contraindicated in severe RHF and concurrent use of PDE-5
inhibitor</td>
</tr>
</tbody>
</table>

<table>
<colgroup>
<col style="width: 16%" />
<col style="width: 17%" />
<col style="width: 15%" />
<col style="width: 20%" />
<col style="width: 30%" />
</colgroup>
<thead>
<tr class="header">
<th colspan="5">Anti-Arrhythmics:</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Drug</td>
<td>Dose</td>
<td>Indications</td>
<td>Side effects</td>
<td>Comments</td>
</tr>
<tr class="even">
<td><strong>Adenosine</strong></td>
<td>6 – 12 mg IV rapid push and flush; may repeat x2</td>
<td>PSVT conversion</td>
<td>Complete AV nodal blockade</td>
<td><p>10 second half-life</p>
<p> Must have continuous EKG/tele monitor</p></td>
</tr>
<tr class="odd">
<td><strong>Amiodarone</strong></td>
<td><p>ACLS: 300 mg IV push</p>
<p>Non-emergent: 150 mg over 10 min then 0.5 mg/min</p></td>
<td>Vtach/Vfib, Afib</td>
<td>Pulm, ophthalmic and thyroid toxicity w/ chronic use</td>
<td>Less hypotension than other agents, safe in heart failure. May
chemically cardiovert patients, caution if off therapeutic AC</td>
</tr>
<tr class="even">
<td><strong>Diltiazem</strong></td>
<td><p>Push: 10 – 20 mg q15 min x 2 if no response</p>
<p>Infusion: 5 – 15 mg/h</p></td>
<td>Afib, Aflutter, PSVT</td>
<td>Bradycardia, hypotension</td>
<td>Avoid use in pts with HFrEF</td>
</tr>
<tr class="odd">
<td><strong>Lidocaine</strong></td>
<td><p>ACLS: 1 mg/kg x 1</p>
<p>Infusion: 1 – 4 mg/min</p></td>
<td>Vtach</td>
<td>Bradycardia, Heart block</td>
<td>Avoid use in liver failure/ Okay for HFrEF. Often 1<sup>st</sup>
line CCU med for VT/ May need to check levels if using for longer than
24 hours</td>
</tr>
<tr class="even">
<td><strong>Procainamide</strong></td>
<td>15 mg/kg over 30 min then 1 – 6 mg/min</td>
<td>Vtach, refractory afib</td>
<td>Bradycardia, hypotension</td>
<td>Drug-induced lupus, cytopenias</td>
</tr>
</tbody>
</table>
